20 min listen
Key Decisions in HIV Care: Switching to a 2-Drug Single-Tablet Regimen
Key Decisions in HIV Care: Switching to a 2-Drug Single-Tablet Regimen
ratings:
Length:
18 minutes
Released:
Nov 10, 2021
Format:
Podcast episode
Description
In this episode, William R. Short, MD, MPH, AAHIVS, explores recommendations and data on switching to 2-drug single-tablet ART regimens.Listen as he gives his perspectives on:Indications for the available 2-drug single-tablet regimens: DTG/RPV and DTG/3TCThe SWORD-1 and SWORD-2 studies evaluating switching to DTG/RPV in virologically suppressed patientsReal-world experience with switching to DTG/RPV from the OPERA studyThe TANGO study evaluating switching to DTG/3TC from a stable TAF-based ART regimenThe SALSA study evaluating switching to DTG/3TC from any stable 3-drug ART regimenPresenter:William R. Short, MD, MPH, AAHIVSAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicinePerelman School of Medicine at the University of PennsylvaniaPhiladelphia, PennsylvaniaFollow along with the slides at:https://bit.ly/3n0Z8wUSee the entire program at:https://bit.ly/2TXTYWx
Released:
Nov 10, 2021
Format:
Podcast episode
Titles in the series (100)
Benefits of and Need for Integrated Addiction and Infectious Disease Care: Listen to an insightful discussion between infectious disease experts, Christian B. Ramers, MD, MPH, and Sandra Springer, MD, on current evidence supporting the need for integrated addiction and infectious disease care services. by CCO Infectious Disease Podcast